5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-imidazole
CAS: 1319255-50-9
Ref. TR-T300940
5g | Ausgelaufen | ||
250mg | Ausgelaufen | ||
2500mg | Ausgelaufen |
Produktinformation
Applications 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-imidazole can be involved in preparation of pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors useful in treating cancer.
References Siddiqui, M., et al.: PCT Int. Appl., WO 2011090935 A1 20110728 (2011)